About ELEM Biotech
ELEM Biotech is a Healthcare company based in Barcelona (Spain) founded in 2018 by Jose Maria Cela, Guillaume Houzeaux, Christopher Morton, and Mariano Vazquez. A simulation-based platform for virtual medical trials is provided. ELEM Biotech has raised $2.27 million across 3 funding rounds from investors including European Union and EIC Fund. Its chief executive, as recorded, is Christopher Morton. ELEM Biotech offers products and services including Virtual Humans Platform and In-Silico Trials Service. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is ELEM Biotech SL.
Company details
ELEM Biotech was founded in 2018 in Barcelona, Spain, within the biotech sector. A platform for medical simulations is offered to support doctors in virtual clinical trials. These trials address cardiac resynchronization, cardiotoxicity, painkiller pumps, valve implants, inhaler flow rates, and drug delivery concentrations. A virtual cardiovascular system is modeled, integrating electrical activity, mechanical deformation, and fluid mechanics. Respiratory simulations are based on fluid mechanics principles.
- Total Equity Funding$2.27M (USD)
in 3 rounds
- InvestorsEuropean Union
& 1 more
Products & Services of ELEM Biotech
ELEM Biotech offers a comprehensive portfolio of products and services, including Virtual Humans Platform and In-Silico Trials Service.
Platform for creating virtual populations in medical testing
Service for conducting virtual trials in drug development
Funding Insights of ELEM Biotech
ELEM Biotech has successfully raised a total of $2.27M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.27M
- Total Rounds 3
- First Round $122,574
(Oct 2020)
- Investors Count 2
All 3 funding rounds of ELEM Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2023 | Grant | – | – | ||
| Dec 2021 | $2.27M | Seed | – | – | – |
| Oct 2020 | $122,574 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in ELEM Biotech
ELEM Biotech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for ELEM Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ELEM Biotech
30 people are tracked at ELEM Biotech (6 in leadership, 10 in board & advisors, 14 in team).
| Name | Role | Group |
|---|---|---|
Jose Maria Cela | Co-Founder | Leadership |
Guillaume Houzeaux | Co-Founder | Leadership |
Christopher Morton | Co-Founder & CEO | Leadership |
Mariano Vazquez | Co-Founder & CTO | Leadership |
Mariano Vázquez | Co-Founder & CTO | Leadership |
Luciana Marques | Head of Communication | Leadership |
Romain Micol | Board Member | Board & advisors |
Paul Iaizzo | Scientific Advisor | Board & advisors |
Oscar Camara | Scientific Advisor | Board & advisors |
Jose María Guerra Ramos | Scientific Advisor | Board & advisors |
Cristóbal Langdon | Scientific Advisor | Board & advisors |
Blanca Rodríguez | Scientific Advisor | Board & advisors |
David Filgueiras Rama | Scientific Advisor | Board & advisors |
Francesc Carreras Costa | Scientific Advisor | Board & advisors |
Roger Assaker | Board Member | Board & advisors |
Jo Pisani | Non Executive Director | Board & advisors |
Arnau Blanco Borrego | Software Developer | Team |
Verónica Montero Castillo | Legal & Compliance Officer | Team |
Eva Casoni | Senior Scientific developer | Team |
Pablo Gonzalez Martin | Biomedical Engineer | Team |
10 more people are available in the full profile.
Complete people profiles for ELEM Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ELEM Biotech
3 dated milestones of ELEM Biotech across 5 years, from founding to its latest funding, stage changes and deals.
- Founded ELEM Biotech is founded.
- Funding First funding round of $123K.
- Funding Latest funding round, Grant,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ELEM Biotech
ELEM Biotech was founded in 2018 and raised its 1st funding round 2 years after it was founded.
ELEM Biotech is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Christopher Morton is the CEO of ELEM Biotech, as recorded in our data. They have also founded this company.
ELEM Biotech is a funded company, having raised a total of $2.27M across 3 funding rounds to date. The company's 1st funding round was a Grant of $122.57K, raised on Oct 2020.
ELEM Biotech was founded in 2018 in Barcelona, Spain, within the biotech sector. A platform for medical simulations is offered to support doctors in virtual clinical trials. These trials address cardiac resynchronization, cardiotoxicity, painkiller pumps, valve implants, inhaler flow rates, and drug delivery concentrations. A virtual cardiovascular system is modeled, integrating electrical activity, mechanical deformation, and fluid mechanics. Respiratory simulations are based on fluid mechanics principles.
ELEM Biotech offers Virtual Humans Platform and In-Silico Trials Service.
ELEM Biotech has 2 investors. Key investors include European Union, and EIC Fund.
ELEM Biotech operates through Elem Biotech Sl.